Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
AI channel feed
The latest healthcare SPAC comes in at $200M with a laser focus on artificial intelligence
4 years ago
Financing
London AI-focused BenevolentAI going public in Europe via $438M SPAC deal
4 years ago
Financing
'We're in': Roche and Genentech join forces on a multibillion-dollar discovery pact with a brash AI upstart
4 years ago
Deals
Bioregnum
Transpacific AI biotech makes its Series A debut — putting $86M in the bank
4 years ago
Financing
Startups
Sanofi continues mRNA push in wake of Covid vaccine setback, partnering with China tech giant Baidu
4 years ago
Deals
Sanofi inks major AI deal to improve clinical development odds with $270M cash investment
4 years ago
Deals
Koch leads mammoth $215M infusion into AI startup boasting 'largest database' of immune cells
4 years ago
Financing
As AI continues to entice Big Pharma, a Carlyle-led drugmaker syndicate shells out $430M for cloud computing player
4 years ago
Financing
Deals
Big Pharma companies join hands with Amazon on new Israel-based AI incubator
4 years ago
Financing
Exscientia tees up an IPO for its AI drug discovery platform, likely not willing to settle for just $100M
4 years ago
Financing
After attracting multiple Chinese pharma partners, XtalPi grabs another $400M to refine AI for drug discovery
4 years ago
Financing
China
Deep Genomics, now flush with cash, plans to take dozens of RNA therapies to the clinic
4 years ago
Financing
A Mubadala-backed biotech is using patient tumor tissue grown in a petri dish to change precision oncology
5 years ago
Financing
A Recursion veteran is mapping plant life to chart a course to new therapies — and investors like what they see
5 years ago
Financing
With a new $255M megaround in hand, Alex Zhavoronkov has big plans for Insilico. Are they feasible?
5 years ago
Financing
Exscientia spends SoftBank's cash in bid to edge out AI rivals
5 years ago
Deals
Flagship and Khosla Ventures team up for biotech's latest SPAC, with Valo Health winning a blank check ticket to Nasdaq
5 years ago
Financing
Deals
Tim Lu is ready to take his AI-focused biotech to the next level with first big fundraising round
5 years ago
Financing
Bristol Myers expands Celgene-era deal with Exscientia, taking its AI R&D engine to the next step
5 years ago
Deals
Dyno's Eric Kelsic fills the tank in his quest for better AAV with a group of big-name supporters on board
5 years ago
Financing
Cell/Gene Tx
Andrew Radin orchestrates his AI discovery platform's pivot to R&D with a harmonious name change and eyes on the clinic
5 years ago
Fueled with a fresh half-billion dollars as AI investments boom, Exscientia is hitting the gas on drug development
5 years ago
Financing
Laying claim to another AI 'first,' Exscientia tees up an I/O drug for the clinic
5 years ago
R&D
With fresh investor cash in hand, Volastra partners with Microsoft to develop metastatic cancer biomarker platform
5 years ago
Financing
Deals
First page
Previous page
8
9
10
11
12
13
14
Next page
Last page